RENDA, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 3.242
EU - Europa 3.004
AS - Asia 1.236
Continente sconosciuto - Info sul continente non disponibili 11
SA - Sud America 2
AF - Africa 1
OC - Oceania 1
Totale 7.497
Nazione #
US - Stati Uniti d'America 3.233
IE - Irlanda 708
CN - Cina 658
UA - Ucraina 627
TR - Turchia 472
SE - Svezia 468
IT - Italia 391
GB - Regno Unito 250
DE - Germania 178
FR - Francia 149
FI - Finlandia 117
BE - Belgio 68
IN - India 56
IR - Iran 20
PL - Polonia 18
VN - Vietnam 16
EU - Europa 10
CA - Canada 8
RU - Federazione Russa 7
IL - Israele 4
NL - Olanda 4
RO - Romania 4
DK - Danimarca 3
JP - Giappone 3
AT - Austria 2
BR - Brasile 2
HU - Ungheria 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BD - Bangladesh 1
BG - Bulgaria 1
CY - Cipro 1
CZ - Repubblica Ceca 1
EG - Egitto 1
GE - Georgia 1
GR - Grecia 1
HK - Hong Kong 1
KH - Cambogia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
MX - Messico 1
RS - Serbia 1
Totale 7.497
Città #
Jacksonville 762
Dublin 691
Chandler 649
Princeton 339
Izmir 225
Nanjing 201
Southend 196
Ashburn 144
Altamura 118
Cambridge 117
Dearborn 117
Wilmington 113
Beijing 104
Nanchang 88
Ann Arbor 79
Brussels 68
Chieti 60
Hebei 39
Shenyang 38
Woodbridge 38
Kunming 37
Boardman 35
New York 29
Tianjin 25
Washington 24
Augusta 23
Jiaxing 23
San Mateo 23
Grevenbroich 22
Norwalk 22
Changsha 21
Leawood 20
Ardabil 17
Dong Ket 15
Falls Church 15
Kraków 15
Hangzhou 14
Pescara 13
Houston 11
Hefei 10
Helsinki 8
Lanzhou 8
Guangzhou 7
Seattle 7
Taizhou 7
Toronto 7
Jinan 6
Monmouth Junction 6
Bologna 5
Düsseldorf 5
Amsterdam 4
Auburn Hills 4
Beersheba 4
Brindisi 4
Fort Worth 4
Fuzhou 4
L'aquila 4
Los Angeles 4
Mumbai 4
Ningbo 4
Redwood City 4
Tappahannock 4
Teramo 4
Bangalore 3
Campodipietra 3
Changchun 3
Florence 3
Intra 3
Kocaeli 3
Mountain View 3
Penne 3
Pune 3
Solofra 3
Spoltore 3
Zhengzhou 3
Ardea 2
Bari 2
Budapest 2
Chicago 2
Chongqing 2
Copenhagen 2
Cormeilles-en-Parisis 2
Giulianova 2
London 2
Milan 2
Orange 2
Osimo 2
Redmond 2
Rome 2
Roseto Degli Abruzzi 2
Salerno 2
Serra 2
Tokyo 2
Torino 2
Treglio 2
Trevi 2
Valea 2
Anaheim 1
Andover 1
Ascoli Piceno 1
Totale 4.801
Nome #
Increased left atrial size in obese children and its association with insulin resistance: a pilot study 121
Response to "Pharmacodynamic Interaction Between Aspirin and Ibuprofen: A Plausible Mechanism of Aspirin Resistance" 104
Optimal duration of antiplatelet therapy in recipients of coronary drug-eluting stents 96
Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial 92
Intracardiac thrombi during warfarin anticoagulation - A case report and a brief literature review 86
Genetic determinants of blood pressure responses to caffeine drinking 82
Aneurisma coronarico: scoperta generalmente casuale, prognosi sempre severa? 82
Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy 81
Surgical bleeding after pre-operative unfractionated heparin and low molecular weight heparin for coronary bypass surgery 80
Genetic determinants of cognitive responses to caffeine drinking identified from a double-blind, randomized, controlled trial 79
Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects 78
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs 78
Effects of endurance, resistance and neuro-muscular electrical stimulation trainings to the anthropometric and functional mobility domains in elderly 78
Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease 78
Failure in evoking the trigeminal cardiac reflex by mandibular stretching in healthy volunteers 77
Low-dose naproxen interferes with the antiplatelet effects of aspirin in healthy subjects: recommendations to minimize the functional consequences 76
La gestione del rischio tromboembolico nei pazienti con fibrillazione atriale in Italia: Dati al follow-up del Registro Europeo PREFER in AF 76
Direct Oral Anticoagulants Halve Thromboembolic Events After Cardioversion of AF Compared With Warfarin 74
Thrombotic and hemorrhagic burden in women: Gender-related issues in the response to antithrombotic therapies 72
INCREASED THROMBOXANE PRODUCTION BY MONOCYTE PROSTAGLANDIN ENDOPEROXIDE SYNTHASE-2 IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION. 71
Rapid decline of collateral circulation increases susceptibility to myocardial ischemia: the trade-off of successful percutaneous recanalization of chronic total occlusions 70
Facilitated PCI: Rationale, current evidence, open questions and future directions 70
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. nonselective COX-2 inhibitors 70
The left atrial appendage: from embryology to prevention of thromboembolism 70
Outcomes of anticoagulated patients with atrial fibrillation treated with or without antiplatelet therapy - A pooled analysis from the PREFER in AF and PREFER in AF PROLONGATON registries 70
Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease 69
Increased thromboxane production by monocyte prostaglandin endoperoxide synthase-2 in patients with acute myocardial infarction (pubbl. su Suppl. Circulation) 68
The Role of Multimodality Cardiovascular Imaging in Peripartum Cardiomyopathy 67
History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial 67
Sex Implications in the Response to Anticoagulant Therapy in Atrial Fibrillation ∗ 66
Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects 65
Incomplete suppression of platelet COX-1 activity associated with aspirin-resistant thromboxane biosynthesis in acute coronary syndromes 64
Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper 64
Insulin-Requiring Versus Noninsulin-Requiring Diabetes and Thromboembolic Risk in Patients With Atrial Fibrillation: PREFER in AF 64
EFFECTS OF NIMESULIDE ON CONSTITUTIVE AND INDUCIBLE PROSTANOID BIOSYNTHESIS IN MAN. 63
Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-W 63
An early decline of collateral circulation parallels myocardial ischaemia during percutaneous coronary intervention: a drawback of recanalization of chronic coronary occlusions? 63
Non-vitamin K Antagonist Oral Anticoagulants for Cardioversion in Atrial Fibrillation - An Updated Meta-analysis 62
AF: current and forthcoming antithrombotic therapies 62
New anticoagulants for atrial fibrillation 61
Management of thromboembolic risk in patients with atrial fibrillation in Italy: baseline data from the PREFER in AF European Registry 61
Edoxaban for the Prevention of Thromboembolism in Patients with Atrial Fibrillation and Bioprosthetic Valves 61
Coffee: Health Effects 61
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors 60
Antithrombotic therapy in atrial fibrillation: state of the art and perspectives. 60
Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy 60
Dose- Dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects. 59
Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease 59
Prognostic significance of noncardiac syncope in the general population: A systematic review and meta-analysis 59
Net Clinical Benefit of Non-Vitamin K Antagonist vs Vitamin K Antagonist Anticoagulants in Elderly Patients with Atrial Fibrillation 59
Cardiovascular and psychological reactivity after caffeine consumption 58
Atrial and left atrial appendage thrombosis in patients with atrial fibrillation: from pathophysiology to treatment 57
Systolic and diastolic dysfunction occurs in newly diagnosed patients with hypertension and high systolic blood pressure variability 56
Cardiovascular effects of caffeine during cognitive tasks 56
CHA2DS2VASc score and adverse outcomes in middle-aged individuals without atrial fibrillation 56
MECHANISMS OF ISOPROSTANE BIOSYNTHESIS IN HUMANS 55
Dose-dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects 55
Platelet Indices and Risk of Death and Cardiovascular Events: Results from a Large Population-Based Cohort Study 55
Blood pressure modifications after caffeine intake during cognitive tasks 54
A comparison between unfractioned heparin and a low molecular weight heparin in cardiac surgery 54
Antithrombotic management 54
Enhanced thromboxane biosynthesis in patients with colorectal and lung cancer 54
Effect of fibrinogen concentration and platelet count on the inhibitory effect of abciximab and tirofiban 53
The AVERROES Trial – Clinical Implications 53
Antithrombotic prophylaxis in the elderly with atrial fibrillation 53
DIFFERENTIAL INHIBITION OF HUMAN PROSTAGLANDIN ENDOPEROXIDE SYNTHASE-1 AND -2 BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS 52
Parmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects 52
Systolic and diastolic dysfunction occurs in newly diagnosed patients with hypertension and high systolic blood pressure variability 52
The legacy of ISCHEMIA 52
Prognostic value of non-resistant and resistant masked uncontrolled hypertension detected by ambulatory blood pressure monitoring 52
EFFECTS OF NIMESULIDE ON CONSTITUTIVE AND INDUCIBLE PROSTANOID BIOSYNTHESIS IN HUMAN BEINGS 51
Frequent and possibly inappropriate use of combination therapy with an oral anticoagulant and antiplatelet agents in patients with atrial fibrillation in Europe. 51
ENHANCED CORTISOL SECRETION DOES NOT CONTROL ASPIRIN-INSENSITIVE THROMBOXANE BIOSYNTHESIS IN PATIENTS WITH ACUTE CORONARY SYNDROMES 50
ENHANCED CORTISOL SECRETION DOES NOT CONTROL ASPIRIN-INSENSITIVE THROMBOXANE BIOSYNTHESIS IN PATIENTS WITH ACUTE CORONARY SYNDROMES. 50
Autonomic nervous system dysfunction in obese children 50
Surgical bleeding after preoperative unfractionated heparin and low molecular weight heparin at coronary bypass surgery 50
Awake blood pressure variability, inflammatory markers and target organ damage in newly diagnosed hypertension 49
Nutrigenetics of blood pressure responses to coffee drinking 49
A comparison between unfractionated heparin and a low molecular weight heparin in cardiac surgery 49
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors 49
Effect of fibrinogen concentration on the antiplatelet effect of tirofiban 49
Systolic blood pressure response to coffee is modulated by alpha2B adrenergic receptor I/D polymorphism 48
Ruolo del fibrinogeno e della conta piastrinica sull’inibizione dell’aggregazione piastrinica da parte dei farmaci anti-glicoproteina IIbIIIa 48
Aspirin Resistance 48
P6223Relationship between platelet indices and future cardiovascular events: results from a population-based cohort study 48
Late coronary thrombosis after drug-eluting stent: stent vs patient-driven prescription of aspirin-clopidogrel combination 48
Circadianicity of hemostatic function and coronary vasomotion 47
Aspirina ed ACE-inibitori. Una partita ancora aperta? 47
Triple antithrombotic therapy with aspirin, clopidogrel and warfarin – a persisting dilemma 47
Celecoxib, ibuprofen and the antiplatelet effect of aspirin in patients with osteoarthritis and chronic stable angina 46
Systolic blood pressure variability by non-invasive monitoring predicts intima-media thickness independent of absolute blood pressure levels 46
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 46
Systolic blood pressure variability by non-invasive monitoring predicts intima-media thickness independent of absolute blood pressure levels 45
Terapia dell’infarto miocardico e delle sindromi coronariche 45
Impact of antiplatelet therapy in heart disease 45
Anticoagulant Therapy in Atrial Fibrillation – Time for a Change? 45
Inhibitory effect of coffee on platelet aggregation 45
The co-predictive value of a cardiovascular score for CV outcomes in diabetic patients with no atrial fibrillation 45
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants After Cardioversion for Nonvalvular Atrial Fibrillation 45
HETEROGENEITY IN THE SUPPRESSION OF PLATELET CYCLOOXYGENASE-1 ACTIVITY BY ASPIRIN IN CARDIOVASCULAR DESEASE. 44
Totale 6.086
Categoria #
all - tutte 26.682
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.682


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019308 0 0 0 0 0 0 0 9 15 5 10 269
2019/20201.595 521 122 13 47 141 79 194 150 62 98 162 6
2020/2021951 131 4 145 25 112 171 22 22 36 103 142 38
2021/2022693 12 5 5 126 82 8 17 62 64 18 72 222
2022/20232.063 183 282 117 193 181 392 166 160 269 26 53 41
2023/2024797 79 22 58 15 61 300 221 41 0 0 0 0
Totale 8.083